Antiviral Therapies in Pediatric Influenza: What Does the Current Data Say?

Program Overview

In order to possess a working knowledge of the latest therapeutic advances and treatment strategies, clinicians need to stay up-to-date on the latest clinical data. This activity will consist of a 15-minute video-based presentation by one nationally recognized expert in the treatment of pediatric influenza focused on the latest clinical data and critical analysis of late-breaking clinical trial data in order to help clinicians stay current and provide optimal care for patients.

0.25 CE Credit(s)

Expires: December 8, 2023

Target Audience

Pediatricians, family practice, and primary care clinicians managing pediatric patients with influenza.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Differentiate between antiviral therapies for influenza prevention and treatment in young children according to their efficacy and safety

Personalize antiviral therapy for influenza prevention and treatment in pediatric patients

Activity Faculty

Charles P. Vega, MD, FAAFP

Assistant Dean, Culture and Community Education
School of Medicine
University of California – Irvine
Irvine, CA

Considering Therapies for Influenza Treatment and Post-Exposure in Children

Provider Statement

This activity is provided by RMEI Medical Education, LLC

Supporter Statement

This activity is supported by an educational grant from Genentech, a member of the Roche Group. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 